| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/28/2011 | US7968558 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 06/28/2011 | US7968557 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 06/28/2011 | US7968556 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 06/28/2011 | US7968555 Intermediates in the preparation of entecavir via carbon-silicon oxidation |
| 06/28/2011 | US7968554 Pyrazolo[3,4-d]pyrimidine derivatives |
| 06/28/2011 | US7968553 Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors |
| 06/28/2011 | US7968552 Oxadiazolidinedione compound |
| 06/28/2011 | US7968551 Chromenoneindoles |
| 06/28/2011 | US7968550 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
| 06/28/2011 | US7968549 Diarylmethylpiperazines as therapeutic agents for viral myocarditis |
| 06/28/2011 | US7968548 Melanocortin receptor-specific piperazine compounds with diamine groups |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968546 Pyridazinone kinase inhibitors |
| 06/28/2011 | US7968545 Compositions useful as inhibitors of voltage-gated ion channels |
| 06/28/2011 | US7968544 Modulators of toll-like receptor 7 |
| 06/28/2011 | US7968543 Methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea to treat proliferative disease |
| 06/28/2011 | US7968542 Thiophene compounds and thrombopoietin receptor activators |
| 06/28/2011 | US7968541 Crystalline form of N-[[4-fluoro-2-(5-methyl-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-C][1,4]-oxazine-2-carboxamide, sodium salt monohydrate |
| 06/28/2011 | US7968540 Spirohydantoin tricyclic CGRP receptor antagonists |
| 06/28/2011 | US7968539 Quinoline derivatives and uses thereof |
| 06/28/2011 | US7968538 Substituted arylamine compounds and methods of treatment |
| 06/28/2011 | US7968536 Heterocyclic compounds useful as RAF kinase inhibitors |
| 06/28/2011 | US7968535 Antidiabetic agents; neurodegenerative disorders; mixture with immunosuppresants |
| 06/28/2011 | US7968534 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
| 06/28/2011 | US7968533 Ethyl nitrite as a gastrointestinal smooth muscle relaxant and diagnostic and therapeutic uses thereof |
| 06/28/2011 | US7968532 Treatment of gynecomastia with 4-hydroxy tamoxifen |
| 06/28/2011 | US7968531 Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis |
| 06/28/2011 | US7968530 Organic derivatives, their salts and use for the control of phytopathogens |
| 06/28/2011 | US7968529 Use of sphingolipids for reducing high plasma cholesterol and high triacylglycerol levels |
| 06/28/2011 | US7968528 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 06/28/2011 | US7968527 Inhibition of FGF signaling |
| 06/28/2011 | US7968525 Use of RNA interference to validate new termiticide target sites and a method of termite control |
| 06/28/2011 | US7968524 Methods of enhancing long term memory formation by inhibition of Gpr12 |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968522 Treatment and prophylaxis of sepsis and septic shock |
| 06/28/2011 | US7968521 Stable cystal of protected pseudouridine |
| 06/28/2011 | US7968511 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis |
| 06/28/2011 | US7968337 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 06/28/2011 | US7968129 Cosmetic skin care complex with anti-aging effect |
| 06/28/2011 | US7968127 Reverse vitamin K effect via photodynamic oxidation targeted at vascular endothelium, fibrin and blood platelets |
| 06/28/2011 | US7968124 Administering anesthetics to a patient; performing a medical, clinical or surgical procedure or observation; administering particles of reversed cubic phase or reversed hexagonal phase material to attenuate anesthetizing effects of the anesthetics |
| 06/28/2011 | US7968123 Complexing agents for compositions containing inclusion complexes |
| 06/28/2011 | US7968122 Anti-viral pharmaceutical compositions |
| 06/28/2011 | US7968120 Modified release dosage forms |
| 06/28/2011 | US7968118 Anti-acid pharmaceutical composition in powder form and process for making it |
| 06/28/2011 | US7968116 Antitumor agent |
| 06/28/2011 | US7968112 Lipids containing omega-3 and omega-6 fatty acids |
| 06/28/2011 | US7968104 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 06/28/2011 | US7968089 Proteoglycan degrading mutants for the treatment of CNS |
| 06/28/2011 | US7968085 Hydrogel formulations |
| 06/28/2011 | US7968082 Evaluating mixtures of low molecular weight heparins by NMR |
| 06/28/2011 | DE202011004861U1 Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von Haut- und Bindegewebserkrankungen Medicinal or dietary supplement for the treatment and / or prophylaxis of skin and connective tissue diseases |
| 06/28/2011 | CA2649083C 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 06/28/2011 | CA2645291C Dibenzyl amine derivatives as cetp inhibitors |
| 06/28/2011 | CA2641667C Composition for optimizing muscle performance during exercise |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/28/2011 | CA2614529C Pyridazinone derivatives as thyroid hormone receptor agonists |
| 06/28/2011 | CA2602248C Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 06/28/2011 | CA2563800C Spinosyns for wound healing |
| 06/28/2011 | CA2531687C Thermosensitive polymers for therapeutic use and methods of preparation |
| 06/28/2011 | CA2529009C Method for obtaining a natural mixture of conjugated equine estrogens |
| 06/28/2011 | CA2526562C Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 06/28/2011 | CA2512608C (2-carboxamido)(3-amino) thiophene compounds |
| 06/28/2011 | CA2508330C Pesticidal 1-aryl-3-amidoxime-pyrazole derivatives |
| 06/28/2011 | CA2506603C Nutritional compositions |
| 06/28/2011 | CA2502347C 9a-azalides with anti-inflammatory activity |
| 06/28/2011 | CA2496241C 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 06/28/2011 | CA2494700C Calcium receptor modulating compound and use thereof |
| 06/28/2011 | CA2494613C Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 06/28/2011 | CA2479039C 2,2-bis(hydroxymethyl)cyclopropylidenemethyl -purines and -pyrimidines as antiviral agents |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2465832C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 06/28/2011 | CA2460026C Porous ceramic composite bone grafts |
| 06/28/2011 | CA2445834C Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 06/28/2011 | CA2436342C Coated vascular filters |
| 06/28/2011 | CA2427206C Sulfamides as gamma-secretase inhibitors |
| 06/28/2011 | CA2424830C Composition comprising fucose and vitamin c and/or vitamin a |
| 06/28/2011 | CA2413086C Benzothiazole derivatives |
| 06/28/2011 | CA2393042C Antithrombotic compound |
| 06/28/2011 | CA2383841C Chemical peeling agent |
| 06/28/2011 | CA2382497C Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 06/28/2011 | CA2380305C Streptogramin derivatives, production thereof and compositions containing the same |
| 06/28/2011 | CA2377909C Pharmaceutical composition containing fenofibrate and preparation method |
| 06/28/2011 | CA2332179C Uses of dna-pk |
| 06/28/2011 | CA2324301C Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 06/28/2011 | CA2322008C 2'-fluoronucleosides |
| 06/28/2011 | CA2315976C Serine protease inhibitors |
| 06/28/2011 | CA2190293C Method of cancer treatment by p53 protein control |
| 06/23/2011 | WO2011075747A1 Therapeutic compounds |
| 06/23/2011 | WO2011075741A1 Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb) |
| 06/23/2011 | WO2011075736A1 Multifunctional zwitterionic polymer conjugates |
| 06/23/2011 | WO2011075725A1 Methods and compositions related to clot-binding compounds |
| 06/23/2011 | WO2011075699A2 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 06/23/2011 | WO2011075684A1 Prodrugs of inhibitors of plasma kallikrein |
| 06/23/2011 | WO2011075665A2 Beta-cell replication promoting compounds and methods of their use |
| 06/23/2011 | WO2011075655A1 Methods and compositions for treating peripheral vascular disease |
| 06/23/2011 | WO2011075643A1 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 06/23/2011 | WO2011075631A1 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | WO2011075630A1 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| 06/23/2011 | WO2011075628A1 Heterocyclic compounds and their uses |